Welcome to LookChem.com Sign In|Join Free

CAS

  • or

63255-29-8

Post Buying Request

63255-29-8 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

63255-29-8 Usage

Safety Profile

Moderately toxic by intravenous and intraperitoneal routes. Warning: This substance is spontaneously combustible. When heated to decomposition it emits toxic vapors of lithium.

Check Digit Verification of cas no

The CAS Registry Mumber 63255-29-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,2,5 and 5 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 63255-29:
(7*6)+(6*3)+(5*2)+(4*5)+(3*5)+(2*2)+(1*9)=118
118 % 10 = 8
So 63255-29-8 is a valid CAS Registry Number.
InChI:InChI=1/C4H8O3.Li/c5-3-1-2-4(6)7;/h5H,1-3H2,(H,6,7);/q;+1/p-1

63255-29-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name Lithium 4-hydroxybutanoate

1.2 Other means of identification

Product number -
Other names lithium hydroxybutyrate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:63255-29-8 SDS

63255-29-8Upstream product

63255-29-8Downstream Products

63255-29-8Relevant articles and documents

HISTONE DEMETHYLASE INHIBITORS

-

Paragraph 00763; 00764, (2014/06/24)

Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

8-Azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

-

Page/Page column 40, (2008/06/13)

The invention provides novel 8-azabicyclo[3.2.1]octane compounds of formula (I): wherein R1, R2, R3, A, and G are defined in the specification, or a pharmaceutically-acceptable salt or solvate thereof, that are antagonists at the mu opioid receptor. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat conditions associated with mu opioid receptor activity, and processes and intermediates useful for preparing such compounds.